Cargando…
The macrophage: Switches from a passenger to a driver during anticancer therapy
We have recently discovered that BRAF inhibitors induce potent macrophage responses that confer melanoma resistance to therapy. Our studies lay a foundation for the hypothesis that macrophages switch their role from a passenger to a driver for tumor survival during therapeutic treatment, suggesting...
Autores principales: | Wang, Tao, Feldman, Gerald M, Herlyn, Meenhard, Kaufman, Russel E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4635944/ https://www.ncbi.nlm.nih.gov/pubmed/26587324 http://dx.doi.org/10.1080/2162402X.2015.1052929 |
Ejemplares similares
-
Immunotargeting of tumor subpopulations in melanoma patients: A paradigm shift in therapy approaches
por: Maurer, Margarita, et al.
Publicado: (2012) -
An apolipoprotein A-I mimetic targets scavenger receptor A on tumor-associated macrophages: A prospective anticancer treatment?
por: Neyen, Claudine, et al.
Publicado: (2013) -
Addressing a weakness of anticancer therapy with mitosis inhibitors: Mitotic slippage
por: Balachandran, Riju S., et al.
Publicado: (2017) -
An anticancer therapy-elicited immunosurveillance system that eliminates tetraploid cells
por: Senovilla, Laura, et al.
Publicado: (2013) -
Epigenetic remodeling combined with photodynamic therapy elicits anticancer immune responses
por: Wachowska, Malgorzata, et al.
Publicado: (2014)